Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Oct 07, 2024

BUY
$21.9 - $28.28 $7.16 Million - $9.24 Million
326,876 Added 22.85%
1,757,153 $41.4 Million
Q1 2024

May 09, 2024

BUY
$21.9 - $28.28 $7.16 Million - $9.24 Million
326,876 Added 22.85%
1,757,153 $41.4 Million
Q4 2023

Oct 07, 2024

BUY
$19.54 - $28.66 $7.97 Million - $11.7 Million
408,024 Added 39.91%
1,430,277 $39.1 Million
Q4 2023

Feb 12, 2024

BUY
$19.54 - $28.66 $7.97 Million - $11.7 Million
408,024 Added 39.91%
1,430,277 $39.1 Million
Q3 2023

Oct 07, 2024

BUY
$21.15 - $27.96 $21.6 Million - $28.6 Million
1,022,253 New
1,022,253 $27.7 Million
Q3 2023

Nov 13, 2023

BUY
$21.15 - $27.96 $21.6 Million - $28.6 Million
1,022,253 New
1,022,253 $27.7 Million
Q2 2022

Aug 12, 2022

SELL
$15.06 - $30.65 $2.07 Million - $4.22 Million
-137,607 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$23.26 - $42.41 $3.7 Million - $6.74 Million
-158,885 Reduced 53.59%
137,607 $4.02 Million
Q4 2021

Feb 11, 2022

SELL
$37.54 - $57.51 $20.3 Million - $31.1 Million
-540,346 Reduced 64.57%
296,492 $12.6 Million
Q3 2021

Nov 09, 2021

SELL
$45.91 - $59.67 $717,848 - $933,000
-15,636 Reduced 1.83%
836,838 $41.7 Million
Q2 2021

Aug 11, 2021

SELL
$43.3 - $67.17 $19.4 Million - $30.1 Million
-447,583 Reduced 34.43%
852,474 $50 Million
Q1 2021

May 11, 2021

BUY
$44.11 - $90.64 $42 Million - $86.3 Million
952,141 Added 273.67%
1,300,057 $76 Million
Q4 2020

Feb 09, 2021

BUY
$33.89 - $49.88 $1.99 Million - $2.93 Million
58,641 Added 20.27%
347,916 $16.2 Million
Q3 2020

Nov 12, 2020

BUY
$26.91 - $37.47 $1.53 Million - $2.13 Million
56,936 Added 24.51%
289,275 $9.76 Million
Q2 2020

Aug 14, 2020

BUY
$19.21 - $28.53 $4.46 Million - $6.63 Million
232,339 New
232,339 $6.36 Million

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $436M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.